Publisert 07.05.2018

Updated share info May 7th 2018

Regenics AS provides updated share info and shareowner distribution as per May 7th 2018

Regenics AS provides updated share info and shareowner distribution as per May 7th 2018, following a succesfull share issue at 17.15 NOK per share. The total number of shares in the company per may 7th 2018 is 6.112.330 valuing the company to approx. 104 million NOK (104 825 945)

For more infor contact CEO Henrik Lund

henrik.lund@regenics.no     0047 90971219

 

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.